Ansell Ltd (ANSLF)
15.05
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Ansell Price to Book Value: 1.197 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.197 |
| May 02, 2024 | 1.197 |
| May 01, 2024 | 1.197 |
| April 30, 2024 | 1.197 |
| April 29, 2024 | 1.197 |
| April 26, 2024 | 1.197 |
| April 25, 2024 | 1.197 |
| April 24, 2024 | 1.197 |
| April 23, 2024 | 1.197 |
| April 22, 2024 | 1.197 |
| April 19, 2024 | 1.197 |
| April 18, 2024 | 1.197 |
| April 17, 2024 | 1.197 |
| April 16, 2024 | 1.197 |
| April 15, 2024 | 1.197 |
| April 12, 2024 | 1.197 |
| April 11, 2024 | 1.197 |
| April 10, 2024 | 1.197 |
| April 09, 2024 | 1.197 |
| April 08, 2024 | 1.197 |
| April 05, 2024 | 1.197 |
| April 04, 2024 | 1.197 |
| April 03, 2024 | 1.197 |
| April 02, 2024 | 1.197 |
| April 01, 2024 | 1.197 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.197 |
| March 27, 2024 | 1.197 |
| March 26, 2024 | 1.197 |
| March 25, 2024 | 1.197 |
| March 22, 2024 | 1.197 |
| March 21, 2024 | 1.197 |
| March 20, 2024 | 1.212 |
| March 19, 2024 | 1.212 |
| March 18, 2024 | 1.212 |
| March 15, 2024 | 1.212 |
| March 14, 2024 | 1.212 |
| March 13, 2024 | 1.296 |
| March 12, 2024 | 1.296 |
| March 11, 2024 | 1.296 |
| March 08, 2024 | 1.296 |
| March 07, 2024 | 1.296 |
| March 06, 2024 | 1.296 |
| March 05, 2024 | 1.296 |
| March 04, 2024 | 1.296 |
| March 01, 2024 | 1.296 |
| February 29, 2024 | 1.296 |
| February 28, 2024 | 1.296 |
| February 27, 2024 | 1.296 |
| February 26, 2024 | 1.296 |
| February 23, 2024 | 1.296 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.037
Minimum
Nov 09 2023
2.759
Maximum
Feb 18 2021
1.717
Average
1.645
Median
Jan 17 2023
Price to Book Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 1.998 |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -- |
Price to Book Value Related Metrics
| PE Ratio | 18.40 |
| PS Ratio | 1.187 |
| Price | 15.05 |
| Earnings Yield | 5.44% |
| Market Cap | 1.878B |
| Operating PE Ratio | 22.73 |
| Normalized PE Ratio | 18.40 |